Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2012
10/10/2012CN102716095A Paclitaxel vesicle type phospholipid gel injection
10/10/2012CN102716093A Sprida freeze-dried powder injection and its preparation method
10/10/2012CN102716089A Gemcitabine hydrochloride liposome injection
10/10/2012CN102716088A Folate coupled chitosan ligustrazine nanoparticle preparation
10/10/2012CN102716086A Carboxylated polyethylene glycol-polylactic acid segmented copolymer brucine nanoparticles and application thereof
10/10/2012CN102716085A Topotecan hydrochloride liposome injection
10/10/2012CN102716081A Docetaxel vesicle type phospholipid gel injection
10/10/2012CN102716080A Suspension containing andrographolide solid lipid nanoparticles as well as preparation method and application of suspension
10/10/2012CN102716068A Method for carrying therapeutic substances into cells
10/10/2012CN102715756A Taxus chinensis slow-releasing body-building mattress and manufacturing method
10/10/2012CN102389559B Traditional Chinese medicine composition and application as radiotherapy sensitizer
10/10/2012CN102276683B Smilaxchinoside compound
10/10/2012CN102258474B Preparation method of self-microemulsifying coenzyme Q10 powdery dry emulsion
10/10/2012CN102228494B Traditional Chinese medicine composition for supporting healthy energy, strengthening human body immunity, resisting fatigue and tumors, and delaying aging
10/10/2012CN102225914B 3-alkenyl-4-aldehyde-5-aryl-4-isoxazoline compound, preparation method thereof and purpose thereof
10/10/2012CN102204933B Preparation method of biological anti-tumor product
10/10/2012CN102204927B Medicament for treating endoplasmic reticulum (ER) breast cancer
10/10/2012CN102178791B Toxin expelling and acne removing agent and preparation method and use method thereof
10/10/2012CN102159187B A nano-emulsion injection of vinca alkaloids and the preparation method thereof
10/10/2012CN102138896B Clofarabine injection and preparation method thereof
10/10/2012CN102127172B Water-soluble coenzyme Q 10 compound and preparation method thereof
10/10/2012CN102068702B Lactosyl-norcantharidin phospholipid compound and preparation method thereof
10/10/2012CN102028958B Composite tumor gene vaccine taking bacterial nano magnetosome as carrier and preparation method thereof
10/10/2012CN101987847B Novel heterocyclic NF-kB inhibitors
10/10/2012CN101947225B Anticancer application of alkaloid
10/10/2012CN101941994B Method for preparing selenium manno-oligosaccharide
10/10/2012CN101830847B Anticancer compound and preparation method thereof
10/10/2012CN101804192B CTLA4lg and derivatives thereof used for resisting tumors
10/10/2012CN101717411B Methyl-removal cantharidin derivative phosphate disodium salt and synthesis method and application thereof
10/10/2012CN101715452B Azaindole-indole coupled derivatives, preparation methods and uses thereof
10/10/2012CN101560175B Thiourea derivatives and preparation method and use thereof
10/10/2012CN101537081B Matsutake health-care medicinal liquor with anticancer function and human body immunizing power enhancement function
10/10/2012CN101536980B Rubescensin preparation and preparation method and use of same
10/10/2012CN101531570B 1,2-substituted-5-acetylenyl-(or 10,11-dihydro)-5H-diphenyl[a,d] suberne (alkyl)-5-alcohol, synthesizing method and application
10/10/2012CN101479249B Benzimidazole derivatives, method for the production thereof, their use as FXR agonists and pharmaceutical preparations containing the same
10/10/2012CN101472921B Pyridylisoxazole derivative
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101450086B Preparation method of leucocytopenia adjuvant
10/10/2012CN101444624B Medicine for cancer therapy
10/10/2012CN101411779B Chinese medicine effective component composition for treating liver cancer and method for preparing the same
10/10/2012CN101405285B Cyclic-alkylaminederivatives as inhibitors of the interaction between MDM2 and P53
10/10/2012CN101400670B Novel pyridine derivative having anti-helicobacter pylori activity
10/10/2012CN101370784B Compound serving as ERK inhibitors
10/10/2012CN101248105B Polymer conjugates of K-252a and derivatives thereof
10/10/2012CN101229127B Liposome preparation
10/10/2012CN101228161B Pyrrolopyridines useful as inhibitors of protein kinase
10/10/2012CN101193912B Acute leukemia and lymphoblastic lymphoma-specific cd43 epitope and use thereof
10/10/2012CN101082043B Polyethylene glycol modified L-asparaginyl amine enzyme
10/10/2012CN101077867B Bis-aryl sulfonamides
10/10/2012CN101023074B Inhibitors of the interaction between MDM2 and P53
10/10/2012CN101010002B Cancer selective auxotrophs
10/09/2012US8283381 Conjugated psychotropic drugs and uses thereof
10/09/2012US8283363 Carboxamide compounds and their use as calpain inhibitors
10/09/2012US8283330 Modulators of pharmacological agents
10/09/2012US8283164 Liver engrafting cells, assays, and uses thereof
10/09/2012US8282935 Intensify immunology response; administering epitopes; polynucleotide sequences
10/09/2012US8282925 Method for treating rheumatoid arthritis using anti-S100A9 antibody
10/09/2012CA2674803C Quinazoline derivatives as angiogenesis inhibitors
10/09/2012CA2634902C Anticancer agent comprising a peptide
10/09/2012CA2633516C Elongase genes and uses thereof
10/09/2012CA2550598C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method and their use in therapy
10/09/2012CA2520475C Tumor-targeting drug-loaded particles
10/09/2012CA2507100C 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/09/2012CA2459347C Locked nucleic acid (lna) compositions and uses thereof
10/09/2012CA2455830C Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
10/09/2012CA2451047C Use of picropodophyllin derivatives for treatment of igf-1r mediated disorders
10/09/2012CA2403501C Non-invasive gene targeting to the brain
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/04/2012WO2012135856A2 Very low dose vinorelbine for treatment of cancer
10/04/2012WO2012135818A2 Cancer diagnostics, therapeutics, and drug discovery associated with macropinocytosis
10/04/2012WO2012135759A1 Combinations of akt inhibitor compounds and abiraterone, and methods of use
10/04/2012WO2012135757A2 Methods for treating cancer
10/04/2012WO2012135753A1 Combinations of akt inhibitor compounds and erlotinib, and methods of use
10/04/2012WO2012135736A2 Modulation of signal transducer and activator of transcription 3 (stat3) expression
10/04/2012WO2012135697A2 Novel rho kinase inhibitors and methods of use
10/04/2012WO2012135695A2 Modulation of cellular migration
10/04/2012WO2012135675A2 Methods for increasing efficacy of folr1 cancer therapy
10/04/2012WO2012135669A1 Nitrogen ring containing compounds for treatment of inflammatory disorders
10/04/2012WO2012135666A1 Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications
10/04/2012WO2012135641A2 Aurora kinase inhibitors and methods of making and using thereof
10/04/2012WO2012135630A2 Crk-a novel target for cancer therapy
10/04/2012WO2012135624A1 Treatment of colon cancer using complement inhibitors
10/04/2012WO2012135598A2 Use of il-17d for the treatment and prevention of cancers
10/04/2012WO2012135592A2 Theranostic imaging agents and methods of use
10/04/2012WO2012135588A2 Methods of treating serosal cancer
10/04/2012WO2012135562A2 Polymer conjugates targeting cells and methods related thereto
10/04/2012WO2012135528A2 Galectin-3c combination therapy for human cancer
10/04/2012WO2012135522A2 Process for manufacturing conjugates of improved homogeneity
10/04/2012WO2012135422A2 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
10/04/2012WO2012135338A1 Processes for preparing tofacitinib salts
10/04/2012WO2012135175A1 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
10/04/2012WO2012135166A1 (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
10/04/2012WO2012135160A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
10/04/2012WO2012135152A1 Compositions for inhibiting gene expression and uses thereof
10/04/2012WO2012135149A2 Small molecule modulators of sirt1 activity activate p53 and suppress tumor growth
10/04/2012WO2012135133A1 Lipoxygenase inhibitors
10/04/2012WO2012135081A2 Lin28-mediated control of let-7 biogenesis
10/04/2012WO2012135046A1 Pegylated human hdl particle and process for production thereof
10/04/2012WO2012134446A1 Epiandrosterone and/or androsterone derivatives and method of use thereof
1 ... 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 ... 2211